Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall

Recall #D-1325-2022 · 06/29/2022

Class II: Risk

Recall Details

Recall Number
D-1325-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Mckesson Medical-Surgical Inc. Corporate Office
Status
Terminated
Date Initiated
06/29/2022
Location
Richmond, VA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23 cartons

Reason for Recall

CGMP Deviations: products were stored outside the drug label specifications.

Product Description

Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99.

Distribution Pattern

Nationwide in the USA.

Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office

View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.